GlassScriptPhysician profile
Jorge L Hernandez
NPI 1538243167
$8,717.16
in general payments reported to CMS, 2019-2025
39 companies · $1,403 in 2025
The $1,403 reported for 2025 was more than what 82% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,400 · 2020: $700 · 2021: $1,147 · 2022: $1,507 · 2023: $1,649 · 2024: $912 · 2025: $1,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,946 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,945.72 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,207.44 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $720.92 | 2019-2025 | Tezspire, Breztri |
| Electromed, INC. | $627.92 | 2019-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $563.88 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $477.58 | 2019-2025 | Ofev, Jascayd, Spiriva |
| Genzyme Corporation | $424.37 | 2019-2025 | |
| Baxter Healthcare | $423.10 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Philips North America LLC | $366.46 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Grifols USA, LLC | $352.67 | 2020-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $333.21 | 2021-2025 | Glassia, Hyqvia |
| Genentech USA, INC. | $311.88 | 2019-2022 | |
| Mylan Specialty L.P. | $310.50 | 2019-2024 | Yupelri |
| Novartis Pharmaceuticals Corporation | $245.15 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $154.48 | 2019-2025 | Uptravi |
| Portola Pharmaceuticals, LLC | $145.80 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $130.30 | 2023 | Xerava |
| Lilly USA, LLC | $121.85 | 2025 | Zepbound |
| Pulmonx Corporation | $89.42 | 2023-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Inogen, INC. | $86.29 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mallinckrodt Hospital Products INC. | $84.53 | 2021-2025 | Acthar |
| Advanced Respiratory, INC | $73.88 | 2020-2021 | |
| Amgen INC. | $66.87 | 2023 | Tezspire |
| Insmed, INC. | $63.96 | 2022-2025 | Arikayce |
| Qorumpartners | $44.06 | 2022 | |
| Jazz Pharmaceuticals INC. | $40.59 | 2020-2021 | |
| Vapotherm INC | $27.69 | 2022 | |
| Fisher & Paykel Healthcare INC | $25.50 | 2024 | Fisher & Paykel Healthcare |
| Tactile Systems Technology INC | $21.84 | 2024 | Flexitouch Plus, Entre Plus |
| Bayer Healthcare Pharmaceuticals INC. | $19.80 | 2021 | |
| Resmed Corp | $19.37 | 2024 | |
| Sunovion Pharmaceuticals INC. | $18.00 | 2019 | |
| Abbvie INC. | $16.59 | 2024 | |
| Merck Sharp & Dohme LLC | $16.13 | 2023 | |
| Idorsia Pharmaceuticals US INC | $15.99 | 2023 | Quviviq |
| Verona Pharma, INC. | $15.23 | 2025 | Ohtuvayre |
| Teva Pharmaceuticals USA, INC. | $14.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.43 | 2024 | Eliquis |
| Melinta Therapeutics, LLC | $13.06 | 2021 | |
| Circassia INC. | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.